SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

Zhihu Ding(Blueprint Medicines (United States)), Ronald A. DePinho(The University of Texas MD Anderson Cancer Center)
Nature
February 1, 2011
Cited by 525


Related Papers